From GlobeNewswire:

MannKind Corporation’s CEO, Michael Castagna, will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on Jan. 11, 2024. Interested parties can listen to the webcast by visiting the company’s website. MannKind focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. You can learn more by visiting mannkindcorp.com or following the company on social media.



Read more: MannKind Corporation to Present at 42nd Annual J.P. Morgan